FLAG Merges with Calidi
The merger looks to create a public company focused on developing oncolytic viral therapies with stem cell-based delivery services.
After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.
